Orphan drugs: battleground between social responsibility and concern for the bottom line
Article Abstract:
Pharmaceutical researchers discover beneficial but unprofitable new drugs distributed for compassionate reasons, at no profit to the manufacturer. National Cancer Institute takes over research on some of these "orphan" drugs.
Publisher: American Druggist, Inc.
Publication Name: American Druggist
Subject: Retail industry
ISSN: 0190-5279
Year: 1981
Research, Economic aspects, Surveys, Intellectual property, Pharmaceutical research, United States. National Cancer Institute, Pharmaceutical Manufacturers Association
Publication Name: American Druggist
Subject: Retail industry
ISSN: 0190-5279
Year: 1981
User Contributions:
Comment about this article or add new information about this topic:
Some mfrs weigh promoting Rx brand names to patients
Article Abstract:
Drug manufacturers may aim advertising at patients and provide information for consumer choice.
Publisher: American Druggist, Inc.
Publication Name: American Druggist
Subject: Retail industry
ISSN: 0190-5279
Year: 1981
Prices and rates, Marketing, Information services, Consumers, Generic products
Publication Name: American Druggist
Subject: Retail industry
ISSN: 0190-5279
Year: 1981
User Contributions:
Comment about this article or add new information about this topic:
Subjects list: Drugs
Similar abstracts:
- Abstracts: Where to go in '97. Boating and the bottom line. Next stop Prague, Rome, Vienna ...
- Abstracts: A phone to drive your car and match your outfit. Coaching for the perfect team
- Abstracts: An end to those broken nights. A thousand and one nights at the panto. Prom nights
- Abstracts: The treatment of migraine. How electronic order entry helps retailers' bottom line results
- Abstracts: DTC debated. Frank Foil promoted at Sandoz Pharmaceuticals
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.